Category: Joint ventures/collaborations
-
Lilly, CureVac Partner on RNA Cancer Drugs in $1.8B Deal
Drug maker Eli Lilly and Company and biotechnology company CureVac AG agreed to develop a series of cancer immunotherapies based on CureVac’s messenger RNA technology.
-
Online Game Harnessed to Combat Foodborne Toxins
A consortium of companies and university labs is recruiting participants in an online computer game to design synthetic proteins to neutralize a toxin that contaminates food crops.
-
Roche, Biotech to Discover New Antibiotics
A biotechnology company that discovers new drugs through detailed genomic analysis is partnering with drug maker Roche to find new treatments for bacterial infections that resist current antibiotics.
-
IBM, UC San Diego Partner on Healthy Aging
IBM and University of California at San Diego are launching a joint research project to gain new insights with artificial intelligence on cognitive and gut microbe health in older people.
-
Biotech Licenses Gene Editing for Autoimmune Disorders
A company developing therapies with gene editing technologies is acquiring a new form of gene editing on T-cells in the immune system to treat autoimmune diseases.
-
Geisinger, Pharmas Partner on Diabetes Model
An alliance between the Geisinger Health System and two pharmaceutical companies is developing a computer model to predict long-term health risks of patients with type 2 diabetes.
-
Drug Delivery Technology Licensed in $2B Deals
The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers.
-
Trial Shows Antibody Effective Against Asthma
Results from a large-scale clinical trial show a synthetic antibody, when added to standard treatments, reduces asthma attacks and improves lung functioning.
-
University, Drug Maker Partner on Suicide Genetics
Pharmaceutical company Janssen Research and Development and University of Utah Health in Salt Lake City are studying genetic factors linked to higher suicide risks.
-
MIT, IBM Open Artificial Intelligence Lab
Massachusetts Institute of Technology and IBM are establishing a joint lab to advance the state of knowledge and business impact of artificial intelligence.